Product Strategy Lead

pbThe Opportunity: /b /ppThe Product Strategy Lead is the end‑to‑end owner of integrated Product Strategy for an assigned portfolio of products, accountable for translating commercial ambition and RD strategy into clear, executable manufacturing and operations strategies across the full product lifecycle. /ppThis role serves as the primary strategic integrator across Manufacturing and Technical Operations, Commercial, RD, Business Development, Quality, Regulatory, Supply Chain, Finance, and Network Strategy.

The Product Strategy Lead ensures product‑level decisions regarding investment, capacity, capability, and lifecycle trade‑offs are coherent, value‑driven, and aligned to enterprise priorities, enabling safe, reliable supply of CSL products to patients. /ppActing as the product’s representative in senior governance forums, the Product Strategy Lead shapes and anchors product‑level strategic decisions, ensuring leadership has a clear, fact‑based view of options, risks, trade‑offs, and value implications across time horizons. /ppbThe Role: /b /ppbProduct Strategy Ownership and Integration /b /plipOwns the single, integrated Product Strategy for assigned products, ensuring end‑to‑end alignment across Commercial, RD, BD, and Operations. /p /lilipActs as the product‑level strategy decision owner within Operations, accountable for framing options, recommending trade‑offs, and anchoring

decisions adopted through governance. /p /lilipEnsures product strategies balance cost, risk, speed, supply resilience, and long‑term enterprise value. /p /lipbPortfolio Lifecycle Strategy /b /plipLeads end‑to‑end product lifecycle strategy, including development, launch strategy, growth, optimization, and end‑of‑life decisions. /p /lilipActively manages portfolio trade‑offs across assigned products, including prioritization, sequencing of investments, and capacity or capability allocation. /p /lilipEnsures lifecycle decisions are grounded in both current performance and future portfolio needs. /p /lipbFinancial Investment Framing /b /plipOwns the financial and value framing of product‑level strategy decisions, including investment rationale, scenario analysis, and long‑term value impact. /p /lilipProvides product inputs into Long‑Range Planning (LRP), ensuring commercial assumptions,

manufacturing strategy, and capacity plans are tightly aligned. /p /lilipPartners with Finance to ensure leadership decisions are supported by clear economic logic and value realization expectations. /p /lipbCross Functional Alignment and Orchestration /b /plipLeads and orchestrates cross‑functional stakeholders across TechOps, Network Strategy, RD, Commercial, Supply Chain, Quality, Regulatory, Finance, Procurement, and BD. /p /lilipDrives alignment and resolves conflicts across competing priorities, operating effectively without direct authority. /p /lilipEnsures execution ownership and decision rights are clear following governance outcomes. /p /lipbExecutive Governance Communication /b /plipDevelops and presents decision‑ready recommendations to senior governance bodies including GLT members, NRB, ORB, IBP, and other executive forums. /p /lilipDistills complex technical, regulatory,

manufacturing, and financial information into clear executive narratives. /p /lilipActs as a trusted strategic advisor to senior leaders on product‑level strategy matters. /p /lipbProduct Lifecycle and Portfolio Strategy /b /plipLeads end‑to‑end product lifecycle management, including development, launch, growth, optimization, and end‑of‑life decisions. /p /lilipEnsures portfolio strategy balances near‑term performance with long‑term enterprise value creation. /p /lipbOwns product‑level inputs into Long‑Range Planning (LRP) /b /plipConverts commercial forecasts, Business Development intent, and lifecycle scenarios into clear demand, volume, timing, and risk assumptions /p /lilipEnsures assumptions are internally consistent and defensible across functions /p /lilipActs as the single source of truth for product demand logic in planning cycles /p /lilipIntegrates LRP and capacity decisions

into product lifecycle strategy /p /lilipShapes capacity and network strategy decisions through influence, not ownership /p /lipbWays of Working Strategy Maturity /b /plipContinuously improves Product Strategy ways of working, tools, and governance interfaces across Product Strategy, Network Strategy, IPTs, and Operations. /p /lilipEstablishes clarity on accountability, decision rights, and handoffs to improve speed and quality of execution. /p /lilipContributes to the maturation of product strategy capability across the organization. /p /lipbSkills Experience: /b /plipBS or BA in science and/or engineering (biotechnology, biology, chemistry, pharmacy, engineering or a related sciences). /p /lilipMaster or advanced degree (sciences or business) preferred. /p /lilip15+ years of experience across manufacturing operations, product strategy, supply chain, or lifecycle management within a

regulated pharmaceutical or biotech environment. /p /lilipDemonstrated experience integrating commercial, RD, and manufacturing strategies at enterprise scale. /p /lilipProven experience influencing and presenting to senior executive and C-suite stakeholders. /p /lilipStrong background in portfolio strategy, lifecycle optimization, and investment decision‑making. /p /lilipExperience operating effectively across global, matrixed organizations /p /lilipCapability to work in a global environment across time-zones which may require meeting times outside of a normal business hours. /p /lipUp to 10% domestic and international /pppbbAbout CSL Behring /b /b /p /ppCSL Behring is a global biotherapeutics leader driven by our promise to save lives.

Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. /ppbr/CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma.

Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. /ppTo learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at . /ppbOur Benefits /b /p